Patents by Inventor Vasantha Srikantan

Vasantha Srikantan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer
    Patent number: 7807373
    Abstract: A nucleic acid sequence that exhibits prostate-specific expression and over-expression in tumor cells is disclosed. The sequence and fragments thereof are useful for detecting, diagnosing, preventing, and treating prostate cancer and other prostate related diseases. The sequence is also useful for measuring hormone responsiveness of prostate cancer cells.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: October 5, 2010
    Assignee: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: Shiv Srivastava, Judd W. Moul, Vasantha Srikantan, Zhiqiang Zou
  • Prostate Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
    Publication number: 20100184023
    Abstract: A nucleic acid sequence that exhibits prostate-specific expression and over-expression in tumor cells is disclosed. The sequence and fragments thereof are useful for detecting, diagnosing, preventing, and treating prostate cancer and other prostate related diseases. The sequence is also useful for measuring hormone responsiveness of prostate cancer cells.
    Type: Application
    Filed: July 2, 2008
    Publication date: July 22, 2010
    Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: Shiv Srivastava, Vasantha Srikantan, Zhiqiang Zou, Judd W. Moul
  • Prostate-specific gene, PCGEM1, and the methods of using PCGEM1 to detect, treat, and prevent prostate cancer
    Patent number: 6828429
    Abstract: A nucleic acid sequence that exhibits prostate-specific expression and over-expression in tumor cells is disclosed. The sequence and fragments thereof are useful for detecting, diagnosing, preventing, and treating prostate cancer and other prostate related diseases. The sequence is also useful for measuring hormone responsiveness of prostate cancer cells.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: December 7, 2004
    Assignee: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: Shiv Srivastava, Vasantha Srikantan, Zhiqiang Zou, Judd W. Moul
  • Prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer
    Publication number: 20040146932
    Abstract: A nucleic acid sequence that exhibits prostate-specific expression and over-expression in tumor cells is disclosed. The sequence and fragments thereof are useful for detecting, diagnosing, preventing, and treating prostate cancer and other prostate related diseases. The sequence is also useful for measuring hormone responsiveness of prostate cancer cells.
    Type: Application
    Filed: March 18, 2004
    Publication date: July 29, 2004
    Applicant: Henry M. Jackson Foundation for the Advancement of Military Medicine
    Inventors: Shiv Srivastava, Vasantha Srikantan, Zhiqiang Zou, Judd W. Moul